Oruka Therapeutics, Inc. (ORKA)
NASDAQ: ORKA · Real-Time Price · USD
84.52
+1.10 (1.32%)
At close: Oct 2, 2026, 4:00 PM EDT
84.49
-0.03 (-0.04%)
After-hours: Oct 2, 2026, 7:30 PM EDT
Oruka Therapeutics Employees
Oruka Therapeutics had 68 employees as of December 31, 2025. The number of employees increased by 40 or 142.86% compared to the previous year.
Employees
68
Change (1Y)
40
Growth (1Y)
142.86%
Revenue / Employee
n/a
Profits / Employee
-$1,613,059
Market Cap
5.60B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 68 | 40 | 142.86% |
| Dec 31, 2024 | 28 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| PTC Therapeutics | 991 |
| Travere Therapeutics | 497 |
| Mirum Pharmaceuticals | 433 |
| CRISPR Therapeutics AG | 393 |
| Scholar Rock Holding | 289 |
| Cogent Biosciences | 258 |
| CG Oncology | 142 |
| Kodiak Sciences | 141 |
ORKA News
- 11 days ago - Oruka Therapeutics ORKA-001 data meet base case, says Clear Street - TheFly
- 11 days ago - Oruka Therapeutics announces Week 28 results for ORKA-001 - TheFly
- 11 days ago - Oruka Therapeutics Announces Positive Week 28 Data for ORKA-001 from the Ongoing EVERLAST-A Trial Showing Deepening of Responses Without Additional Dosing - GlobeNewsWire
- 25 days ago - Oruka Therapeutics to Attend the 2026 Morgan Stanley Global Healthcare Conference - GlobeNewsWire
- 5 weeks ago - Oruka Therapeutics appoints Todd Edwards as chief commercial officer - TheFly
- 5 weeks ago - Oruka Therapeutics Appoints Todd Edwards as Chief Commercial Officer - GlobeNewsWire
- 6 weeks ago - Oruka Therapeutics files $1B mixed securities shelf - TheFly
- 6 weeks ago - Oruka Therapeutics Registration statement: Registration filing - Filings